CBD (cannabidiol) is increasingly popular for its numerous health benefits. However, it is essential to be well-informed about potential interactions with other medications, particularly metoprolol. In this article, we will discuss the different characteristics of CBD and metoprolol, as well as their possible interactions.
CBD: What is it?
Cannabidiol (CBD) is a compound extracted from the cannabis plant. Unlike THC, the other major component of cannabis, CBD does not produce psychoactive effects and therefore does not induce a "high." It acts primarily on the body's endocannabinoid system, regulating various physiological processes such as pain, anxiety, and sleep.
Numerous studies have highlighted the therapeutic properties of CBD, such as its anti-inflammatory and antioxidant effects, its ability to reduce stress, anxiety, and even certain forms of epilepsy. It has also demonstrated cardiovascular protective effects in some preclinical research.
Metoprolol: presentation and indications
Metoprolol is a medication belonging to the class of selective beta-blockers. It is marketed under various brand names such as Lopressor, Toprol-XL, Beloc-Zok, and Metohexal. This medication is primarily prescribed to treat cardiovascular problems, including:
- arterial hypertension (HTA)
- angina pectoris (or pectoral angina)
- heart rhythm disorders
- heart attack prevention
Metoprolol works by blocking the stimulation of beta-adrenergic receptors – present in the heart and other parts of the body – by catecholamines (such as adrenaline). This slows the heart rate and reduces the force with which the heart contracts, thus lowering blood pressure.
Potential interactions between CBD and Metoprolol
It is important to note that there is still no solid clinical data regarding potential specific interactions between CBD and Metoprolol.
Inhibition of Metoprolol metabolism
However, some studies have highlighted CBD's potential to inhibit a liver enzyme called cytochrome P450 (CYP450), responsible for metabolizing approximately 60% of drugs available on the market, including Metoprolol.
By inhibiting this enzyme, CBD could increase metoprolole levels in the body and potentially cause side effects such as:
- dizziness
- fatigue
- a significant drop in blood pressure (hypotension)
- an excessive slowing of the heart rate (bradycardia)
These side effects could be particularly concerning in people already prone to these symptoms or in fragile health.
Synergistic effects on cardiovascular properties
As mentioned previously, some preclinical studies have demonstrated a cardiovascular protective effect of CBD. While this may seem beneficial as a first-line treatment, it is difficult to assess, without reliable clinical data, whether this interaction between CBD and metoprolol could lead to positive effects or, conversely, generate undesirable risks.
Precautions and advice
If you are considering taking CBD in conjunction with Metoprolol, we recommend:
- Speak to your doctor or pharmacist before taking any action so they can inform you of the potential risks and adjust your treatments or dosages if necessary
- to carefully monitor for any side effects and report them promptly to your healthcare professional
- To ensure the quality of the CBD product, choose a reliable supplier who is transparent about the certifications, tests, and dosages performed on their merchandise
In summary
It is still difficult to accurately assess the interactions between CBD and metoprolol due to a lack of clinical data. However, some studies suggest that CBD may inhibit the metabolism of metoprolol, potentially leading to adverse effects. If you wish to combine these two substances, it is advisable to consult your doctor to discuss the potential risks and adjust your treatment if necessary.
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.
